Carfizome 60Mg Inj

Carfizome 60Mg Inj is used in the treatment of Multiple Myeloma. The detailed uses of Carfizome 60Mg Inj are as follows:

• Relapsed or refractory multiple myeloma: Carfizome 60Mg Inj is used for the treatment of multiple myeloma in adult patients whose cancer has relapsed or is refractory to one or more lines of therapy. It is specifically indicated when the disease becomes resistant to previous treatments, helping to slow disease progression and extend survival. By targeting cancer cells that have adapted to earlier therapies, Carfizome 60Mg Inj provides a critical second-line or later treatment option.
• Combination therapy support: Carfizome 60Mg Inj is used in combination with other agents such as dexamethasone or lenalidomide to enhance overall treatment efficacy in patients with relapsed or refractory multiple myeloma. These combinations have shown improved response rates and longer progression-free survival compared to monotherapy. The synergy between Carfizome 60Mg Inj and these medications helps increase cancer cell death while maintaining manageable toxicity profiles.
• Proteasome inhibition in cancer therapy: Carfizome 60Mg Inj is used as a selective proteasome inhibitor that blocks the activity of proteasomes, which are cellular structures responsible for breaking down unneeded or damaged proteins. In cancer cells, this inhibition disrupts protein homeostasis and causes toxic proteins to accumulate, leading to cellular stress and programmed cell death (apoptosis). By targeting the increased protein turnover demands of myeloma cells, Carfizome 60Mg Inj effectively eliminates cancer cells while leaving most normal cells relatively unaffected.

Carfilzomib, a proteasome inhibitor, is present in Carfizome 60Mg Inj. It suppresses proteasomes, preventing protein breakdown in MM (multiple myeloma) cells. When proteasome function is stopped within the MM cell, a protein build-up occurs within the MM cell, which destroys the malignant cells.

• Follow your doctor’s instructions on the dosage and timing of this medication.
• Carfizome 60Mg Inj will be administered by a doctor or nurse in a healthcare facility.
• Do not self-administer.

• De-stress yourself by meditating, reading books, taking a warm bubble bath or listening to soothing music.
• Performing yoga may also help in improving both physical and mental health.
• Maintain a healthy weight by performing regular low-strain exercises and eating healthy food.
• Eat a healthy diet and exercise regularly to maintain proper weight.
• Include leafy vegetables, citrus fruits, fatty fish, berries, yoghurt, apples, peaches, cauliflower, cabbage, broccoli, beans, and herbs.
• Get optimal sleep; rest well.
• Avoid smoking and alcohol consumption.
• Avoid fast food, fried food, processed meats, refined carbs and added sugars.

Before taking Carfizome 60Mg Inj, inform your doctor about your medical history and other medications you are currently taking to rule out any potential negative effects. Avoid taking Carfizome 60Mg Inj if you are pregnant or breastfeeding or allergic to any component present in Carfizome 60Mg Inj. Both women and men using this Carfizome 60Mg Inj should use birth control to avoid pregnancy. Inform your doctor right away if you or your partner become pregnant during treatment with Carfizome 60Mg Inj. Inform your doctor if you have a history of heart failure and ischemia, Pulmonary Hypertension, Thrombocytopenia, low blood pressure or hepatic toxicity; your doctor will closely monitor and manage it. Carfilzomib injection may induce serious or life-threatening responses for up to 24 hours following administration. Before each dose of carfilzomib, you will be given specific drugs to assist in preventing a reaction. If you develop any of the following symptoms after your treatment, contact your doctor right away: fever, chills, joint or muscle pain, flushing or swelling of the face, swelling or tightening of the throat, vomiting, weakness, shortness of breath, disorientation or fainting, or chest tightness or pain.